Navigation Links
New scorecard shows inequalities in osteoporosis care in the Europe Union
Date:4/17/2013

Today a panel of international experts working in cooperation with the International Osteoporosis Foundation (IOF) have published SCOPE or Scorecard for Osteoporosis in Europe.

Focusing on key aspects of service provision and uptake, the Scorecard compares how the 27 different countries within the European Union (EU) care for people with osteoporosis to reduce their risk of bone fractures. Fractures, which mostly affect older adults, can result in pain, long-term disability and even premature death.

The Scorecard presents, measures and compares data in a way that is simple to see and interpret, sets benchmarks, and measures critical indicators of overall performance. SCOPE covers four main indicators of osteoporosis:

  • Burden of osteoporosis and fractures, including forecasts for the future
  • Policy framework availability of public health programmes
  • Service provision assessment and treatments of osteoporosis
  • Service uptake e.g. treatment gap, the proportion of men and women at high risk who don't receive treatment

The Scorecard reveals that countries with a higher risk of fracture and incidence of osteoporosis do not always make the largest investment in fracture reduction and treatment. This indicates that services are not aligned or operating efficiently enough to reduce the risk of fractures, which cost in excess of 37 billion and cause about 43,000 deaths each year in Europe. It is hoped that the scorecard will help to inform a Europe-wide strategy for osteoporosis that aims to reduce fractures, costs and the burden in the population.

Several of the key findings of the Scorecard are:

  • The majority of high-risk individuals remain untreated. Less than half of women at high risk of fracture are treated despite the high cost of fractures and the availability of effective medications;
  • Facilities and access to testing for osteoporosis, as well as utilizat
    '/>"/>

Contact: L. Misteli
news@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Ian Lawton Announces the Premier of Soulseeds Radio on PRX with Half-Hour Shows of Wit, Wisdom, and Live Musical Performances at C3 Exchange in Grand Haven, MI.
2. CT and serum LDH shows promise as survival predictor for some metastatic melanoma patients
3. Some minorities believe they are less likely to get cancer compared to whites, Moffitt study shows
4. Study shows severity of sleep apnea is influenced by race
5. Stanford study shows different brains have similar responses to music
6. 2-drug combo more effective in treating sarcomas, Moffitt Cancer Center study shows
7. Experimental Vaccine Shows Promise for Ovarian Cancer
8. 2-step ovarian cancer immunotherapy made from patients own tumor shows promise
9. CAMH study shows mental illness associated with heavy cannabis use
10. More Evidence Shows Hormone Therapy May Increase Breast Cancer Risk
11. New technique shows promise in restoring near vision without glasses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... published online in The Gerontologist ... is associated with a decrease in anxiety about death ... control over their lives. In particular, listening to gospel ... death and an increase in sense of control. , ... and men, and individuals of both low- and high-socioeconomic ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2
... Caring World Experience Features High Tech, Interactive Exhibits, ... (NYSE:,JNJ), Worldwide Partner of the International Olympic Committee ... Paralympic Games, today unveiled,its Olympic Games Pavilion on ... World exhibition, which illustrates the company,s commitment to,caring ...
... Aurora Health Care,has been honored as YMCA of ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080806/AQW060 ), "As Black Achievers, ... Marsha Lee, Black Achievers director at the YMCA ... pursue and set high educational and career goals.", ...
... 6 The thoughts and support of the entire,Susan ... Applegate as she,undergoes treatment for breast cancer., (Logo: ... supporter of Susan G. Komen for the Cure,having championed ... over the years. As the daughter of a breast ...
... System Improves Patient Care, ATLANTA, Aug. ... announced the launch of its new WellCentive,Outreach ... Voice Over,Internet Protocol (VoIP) technology. The WellCentive ... about upcoming,appointments or overdue care, such as ...
... doctors informing patients of this simple preventive approach, study says ... reduce the risk of colon cancer, but few American adults ... sedentary lifestyle accounts for as many as 14 percent of ... get lots of exercise have a 30 percent to 40 ...
... aphasia in Alzheimer,s disease and related forms of dementia following initiation ... related to immune regulation of brain function, providing an exciting new ... ... (PRWEB) August 5, 2008 -- Rapid improvement of aphasia and word-finding ...
Cached Medicine News:Health News:Johnson & Johnson Unveils Olympic Games Pavilion Featuring Authentic Qin Shi Huang Terracotta Warrior Exhibit 2Health News:Johnson & Johnson Unveils Olympic Games Pavilion Featuring Authentic Qin Shi Huang Terracotta Warrior Exhibit 3Health News:Aurora Health Care Employee Named YMCA Black Achiever of the Year 2Health News:Susan G. Komen for the Cure(R) Comments on Christina Applegate's Breast Cancer Diagnosis 2Health News:WellCentive Launches the WellCentive Outreach System 2Health News:WellCentive Launches the WellCentive Outreach System 3Health News:Exercise Lowers Risk of Colon Cancer 2Health News:New Drug May Help Combat Alzheimer's 2Health News:New Drug May Help Combat Alzheimer's 3
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Novagali Pharma, an,emerging pharmaceutical company specialized in ophthalmology,presents ... trial,positive results from the Phase III clinical study ... at the,XIV Afro-Asian Congress of ophthalmology (AACO) held ... , VKC is a severe form of chronic ...
... Interim results in a randomized phase II/III ... 26, 2007 /PRNewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) ... that treatment with pixantrone (BBR,2778) resulted in ... mitoxantrone induced significant cardiac damage.,The studies compared ...
Cached Medicine Technology:Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 2Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 3Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6
... Recently updated with a high resolution ... new Kowa Non Myd - digital ... style and ease of use. Now ... easy to install VK-2 image and ...
... 2000 incorporates a full ... programs in precisely evaluating ... is a full-function, state-of-art ... efficient acquisition, storage, retrieval ...
Nidek LM-990A accomplishes precise measurement, quick response and easy operation....
Autolensmeter with black/white monitor and no internal printer....
Medicine Products: